Prelude Capital Management, LLC Natera, Inc. Transaction History

Prelude Capital Management, LLC

$1.85 Billion
Q1 2024

A detailed history of Prelude Capital Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 27,998 shares of NTRA stock, worth $2.98 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

27,998

Previous 68,567 59.17%

Holding current value

$2.98 Million

Previous $4.3 Million 40.4%

% of portfolio

0.14%

Previous 0.29%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$59.21 - $92.9 $2.4 Million - $3.77 Million	-40,569 Reduced 59.17%	27,998 $2.56 Million
Q4 2023 Feb 14, 2024	SELL	$37.55 - $62.64 $605,343 - $1.01 Million	-16,121 Reduced 19.04%	68,567 $4.3 Million
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $954,756 - $1.38 Million	21,999 Added 35.09%	84,688 $3.75 Million
Q2 2023 Aug 14, 2023	BUY	$47.08 - $55.16 $21,421 - $25,097	455 Added 0.73%	62,689 $3.05 Million
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $934,619 - $1.49 Million	25,557 Added 69.68%	62,234 $3.46 Million

Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $624,730 - $875,938	18,283 Added 99.4%	36,677 $1.47 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $679,290 - $1.04 Million	18,394 New	18,394 $806,000
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $803,874 - $2.42 Million	-26,513 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $234,799 - $323,918	-2,722 Reduced 9.31%	26,513 $2.48 Million
Q3 2021 Nov 15, 2021	BUY	$100.17 - $126.36 $78,633 - $99,192	785 Added 2.76%	29,235 $3.26 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $37,001 - $51,479	-430 Reduced 1.49%	28,450 $3.23 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $2.31 Million - $3.14 Million	25,229 Added 691.02%	28,880 $2.93 Million
Q4 2020 Feb 16, 2021	SELL	$66.66 - $111.74 $76,592 - $128,389	-1,149 Reduced 23.94%	3,651 $363,000
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $220,272 - $348,816	4,800 New	4,800 $347,000
Q1 2020 May 15, 2020	SELL	$17.27 - $40.17 $1,588 - $3,695	-92 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $2,953 - $3,716	92 New	92 $3,000
Q2 2019 Aug 14, 2019	SELL	$17.75 - $27.58 $584,117 - $907,602	-32,908 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.34 - $20.62 $93,033 - $169,166	8,204 Added 33.21%	32,908 $679,000
Q4 2018 Feb 14, 2019	SELL	$12.32 - $24.38 $609,002 - $1.21 Million	-49,432 Reduced 66.68%	24,704 $345,000
Q3 2018 Nov 14, 2018	SELL	$18.82 - $28.96 $230,130 - $354,122	-12,228 Reduced 14.16%	74,136 $1.78 Million
Q2 2018 Aug 14, 2018	SELL	$8.79 - $19.98 $798,219 - $1.81 Million	-90,810 Reduced 51.25%	86,364 $1.63 Million
Q1 2018 May 15, 2018	BUY	$9.0 - $11.95 $648,216 - $860,686	72,024 Added 68.5%	177,174 $1.64 Million
Q4 2017 Feb 14, 2018	SELL	$8.99 - $14.31 $142,518 - $226,856	-15,853 Reduced 13.1%	105,150 $945,000
Q3 2017 Nov 14, 2017	BUY	$8.02 - $13.33 $970,444 - $1.61 Million	121,003	121,003 $1.56 Million

Others Institutions Holding NTRA

# of Institutions

439

Shares Held

117M

Call Options Held

254K

Put Options Held

263K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Natera, Inc. Transaction History